COVID-19 Testing Continues to Lift Aytu BioScience Stock
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been…
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk and Zoom Video Communications.
Friday's top analyst upgrades, downgrades and initiations included Cardinal Health, Domino's, FedEx, Ford, General Electric, Grubhub, HSBC, Marvell Technology, Twitter and Uber.
These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite picks from Raymond James analysts.
These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid portfolio additions at current price levels.
The top analyst upgrades, downgrades and initiations seen on Friday included 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe's and Yelp.
Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value going forward.
The top analyst upgrades, downgrades and initiations seen from Wednesday included Abbott Laboratories, Boston Scientific, CME, DaVita, Skyworks Solutions, Spirit Airlines, Advanced Micro Devices and Nvidia.
The top analyst upgrades, downgrades and other research calls from Thursday include Charter Communications, Corning, Kohl’s, Lululemon, Nike and Verizon.
Here are seven companies that have 50 straight years or more of raising their dividends, as well as several runners-up.